Suppr超能文献

依曲替酯对银屑病皮肤中花生四烯酸代谢的环氧化酶和脂氧化酶产物的影响。

The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.

作者信息

Wong E, Barr R M, Brain S D, Greaves M W, Olins L A, Mallet A I

出版信息

Br J Clin Pharmacol. 1984 Oct;18(4):523-7. doi: 10.1111/j.1365-2125.1984.tb02499.x.

Abstract

Eight psoriatic patients were treated with etretinate (50 mg daily) for 6 weeks. Skin chamber exudates from involved and uninvolved skin were assayed for arachidonic acid, 12-HETE, PGE2 and for neutrophil chemokinetic activity co-chromatographing with leukotriene B4, before and at weekly intervals during therapy. Pre-treatment concentrations of arachidonic acid, 12-HETE and leukotriene B4-like chemokinetic activity but not of PGE2 were elevated in involved skin when compared to uninvolved skin. The concentrations of arachidonic acid and 12-HETE declined during therapy but changes in PGE2 were minimal. LTB4-like activity was detectable in involved skin both before and after etretinate treatment. Clinically, scaling and infiltration improved but erythema was still evident.

摘要

8例银屑病患者接受依曲替酯(每日50毫克)治疗6周。在治疗前及治疗期间每周一次,对受累皮肤和未受累皮肤的皮肤腔渗出物进行花生四烯酸、12-羟基二十碳四烯酸(12-HETE)、前列腺素E2(PGE2)检测,并与白三烯B4进行共色谱分析以检测中性粒细胞趋化活性。与未受累皮肤相比,受累皮肤中花生四烯酸、12-HETE和白三烯B4样趋化活性的预处理浓度升高,但PGE2浓度未升高。治疗期间花生四烯酸和12-HETE的浓度下降,但PGE2的变化最小。在依曲替酯治疗前后,受累皮肤中均可检测到白三烯B4样活性。临床上,鳞屑和浸润有所改善,但红斑仍很明显。

相似文献

1
The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
Br J Clin Pharmacol. 1984 Oct;18(4):523-7. doi: 10.1111/j.1365-2125.1984.tb02499.x.
2
The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.
Prostaglandins. 1984 Jul;28(1):57-65. doi: 10.1016/0090-6980(84)90113-8.
3
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Br J Clin Pharmacol. 1986 Dec;22(6):627-32. doi: 10.1111/j.1365-2125.1986.tb02949.x.
4
Lipoxygenase products of arachidonic acid in human inflamed skin.
Br J Clin Pharmacol. 1985 Sep;20(3):185-90. doi: 10.1111/j.1365-2125.1985.tb05059.x.
5
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
J Invest Dermatol. 1984 May;82(5):477-9. doi: 10.1111/1523-1747.ep12260985.
6
The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility.
Prostaglandins. 1987 Jun;33(6):837-44. doi: 10.1016/0090-6980(87)90112-2.
7
Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
Arch Dermatol Res. 1989;280(8):474-6. doi: 10.1007/BF00427659.
8
Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
J Invest Dermatol. 1984 Dec;83(6):426-30. doi: 10.1111/1523-1747.ep12273519.
9
In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
J Invest Dermatol. 1986 Jul;87(1):47-52. doi: 10.1111/1523-1747.ep12523561.

引用本文的文献

1
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Br J Clin Pharmacol. 1986 Dec;22(6):627-32. doi: 10.1111/j.1365-2125.1986.tb02949.x.
2
The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin.
Br J Clin Pharmacol. 1988 Jan;25(1):23-6. doi: 10.1111/j.1365-2125.1988.tb03277.x.

本文引用的文献

1
The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.
Br J Pharmacol. 1980 Jul;69(3):473-8. doi: 10.1111/j.1476-5381.1980.tb07037.x.
2
Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359).
Br J Dermatol. 1980 Feb;102(2):195-202. doi: 10.1111/j.1365-2133.1980.tb05692.x.
3
Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.
J Am Acad Dermatol. 1983 Jan;8(1):95-102. doi: 10.1016/s0190-9622(83)70012-5.
4
The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.
Prostaglandins. 1984 Jul;28(1):57-65. doi: 10.1016/0090-6980(84)90113-8.
5
The identification of hydroxy fatty acids in psoriatic skin.
Prostaglandins. 1983 Sep;26(3):431-47. doi: 10.1016/0090-6980(83)90178-8.
7
Retinoids are potent inhibitors of the generation of rat leukocyte leukotriene B4-like activity in vitro.
Eur J Pharmacol. 1984 Feb 10;98(1):61-7. doi: 10.1016/0014-2999(84)90109-2.
8
Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.
Br J Pharmacol. 1983 Nov;80(3):497-502. doi: 10.1111/j.1476-5381.1983.tb10721.x.
9
Inhibition of neutrophil migration by etretinate and its main metabolite.
Br J Dermatol. 1982 Dec;107(6):681-5. doi: 10.1111/j.1365-2133.1982.tb00528.x.
10
Psoriasis and leukotriene B4.
Lancet. 1982 Oct 2;2(8301):762-3. doi: 10.1016/s0140-6736(82)90939-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验